GlassScriptPhysician profile
Samantha Mary Dunham
NPI 1124045802
$18,519.12
in general payments reported to CMS, 2019-2025
10 companies · $49.04 in 2025
The $49.04 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2021: $18.91 · 2022: $103 · 2023: $15K · 2024: $3,428 · 2025: $49.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Consulting Fee: $2,965 · Food and Beverage: $1,039 · Travel and Lodging: $343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,896.05 |
| Consulting Fee | $2,965.00 |
| Food and Beverage | $1,038.73 |
| Travel and Lodging | $342.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $12,032.41 | 2023-2024 | Veozah |
| Sumitomo Pharma America, INC. | $5,737.11 | 2023 | Myfembree |
| Novo Nordisk INC | $269.59 | 2023-2024 | |
| Davol INC. | $154.51 | 2023 | |
| Abbvie INC. | $119.37 | 2019 | |
| Gynesonics, INC. | $103.10 | 2022 | |
| Avion Pharmaceuticals | $35.08 | 2019 | |
| Biogen, INC. | $29.57 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $19.47 | 2025 | Myosure Tissue Removal Device |
| Therapeuticsmd, INC. | $18.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantha Dunham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.